Results from Surgical Treatment for Thymoma. 43 Years of Experience

Overview

Journal Jpn J Thorac Cardiovasc Surg

Specialties Cardiology & Vascular Diseases
General Surgery
Pulmonary Medicine

Date 2000 Apr 19

PMID 10769987

Citations 19

Authors

T Murakawa

J Nakajima

T Kohno

M Tanaka

J Matsumoto

E Takeuchi

S Takamoto

Affiliations

Soon will be listed here.

Abstract

Objective: The biological behavior of thymoma and its prognosis after surgical intervention remain still controversial. The efficacy of surgical treatment for thymoma was investigated by examining long-term follow-up data.

Subjects And Methods: Follow-up data for patients undergoing surgical resection of histopathologically-confirmed thymoma between 1954 and 1997 were obtained and were retrospectively analyzed. Clinical staging was based on Masaoka's staging system, and histological classification on Rosai's proposed criteria.

Results: Data for 140 patients were collected. Sixty-four patients had stage I, 32 had stage II, 28 had stage III, and 16 had stage IV thymoma. There were significant differences in survival between patients with stage I and stage III, stage I and stage IV and stage II and stage III disease, but not between those with stage I thymoma and stage II thymoma. No significant difference in survival was observed between the 56 patients with myasthenia gravis (MG) and the 84 without MG. The 38 patients classified as having a predominantly-epithelial thymoma had a poorer prognosis than the 41 with a predominantly-lymphocytic thymoma. Until 1975, there were four patients with stage I thymomas who later showed recurrence, compared with 21 among those with stage II, III and IV diseases. Since 1976, extended thymectomy with thymomectomy under median sternotomy has been adopted as the standard operation for a thymoma, and there has been no recurrence in stage I patients.

Conclusions: Patients with stage III or IV invasive thymoma have a poorer prognosis and a higher recurrence rate than those with encapsulated thymoma, and patients with a predominantly-epithelial thymoma have a poorer prognosis than those with a predominantly-lymphocytic thymoma. Extended thymectomy with thymomectomy under median sternotomy can be considered as adequate treatment for a stage I thymoma. Myasthenia gravis does not appear to affect the prognosis of patients with a thymoma.

Citing Articles

Pathological tumor long-to-short axis ratio as a prognostic factor in patients with thymic epithelial tumors.

Tian D, Shiiya H, Sato M, Shinozaki-Ushiku A, Yan H, Nakajima J Thorac Cancer. 2022; 13(17):2489-2498.

PMID: 35861051 PMC: 9436687. DOI: 10.1111/1759-7714.14582.

How to obtain adequate biopsy specımen in suspected thymic tumors.

Bilaceroglu S J Thorac Dis. 2021; 12(12):7598-7606.

PMID: 33447450 PMC: 7797836. DOI: 10.21037/jtd-2019-thym-14.

Intermediate oncologic outcomes after uniportal video-assisted thoracoscopic thymectomy for early-stage thymoma.

Pupovac S, Newman J, Lee P, Alexis M, Jurado J, Hyman K J Thorac Dis. 2020; 12(8):4025-4032.

PMID: 32944314 PMC: 7475555. DOI: 10.21037/jtd-20-1370.

Tumor location may affect the clinicopathological features and prognosis of thymomas.

Tian D, Shiiya H, Sato M, Sun C, Anraku M, Nakajima J Thorac Cancer. 2019; 10(11):2096-2105.

PMID: 31499597 PMC: 6825910. DOI: 10.1111/1759-7714.13188.

Spontaneous rupture of thymoma.

Sinyagovskiy P, Abdalla M, Raja A, Abdelghani A Respir Med Case Rep. 2018; 26:56-58.

PMID: 30533378 PMC: 6260445. DOI: 10.1016/j.rmcr.2018.11.008.

References

Hishima T, Fukayama M, Fujisawa M, Hayashi Y, Arai K, Funata N . CD5 expression in thymic carcinoma. Am J Pathol. 1994; 145(2):268-75. PMC: 1887382. View

Venuta F, Rendina E, Pescarmona E, De Giacomo T, Vegna M, Fazi P . Multimodality treatment of thymoma: a prospective study. Ann Thorac Surg. 1998; 64(6):1585-91; discussion 1591-2. DOI: 10.1016/s0003-4975(97)00629-2. View

Quintanilla-Martinez L, WILKINS Jr E, Choi N, Efird J, Hug E, Harris N . Thymoma. Histologic subclassification is an independent prognostic factor. Cancer. 1994; 74(2):606-17. DOI: 10.1002/1097-0142(19940715)74:2<606::aid-cncr2820740212>3.0.co;2-t. View

Salyer W, Eggleston J . Thymoma: a clinical and pathological study of 65 cases. Cancer. 1976; 37(1):229-49. DOI: 10.1002/1097-0142(197601)37:1<229::aid-cncr2820370133>3.0.co;2-2. View

Ruffini E, Mancuso M, Oliaro A, Casadio C, Cavallo A, Cianci R . Recurrence of thymoma: analysis of clinicopathologic features, treatment, and outcome. J Thorac Cardiovasc Surg. 1997; 113(1):55-63. DOI: 10.1016/S0022-5223(97)70399-4. View

LEGG M, Brady W . PATHOLOGY AND CLINICAL BEHAVIOR OF THYMOMAS. A SURVEY OF 51 CASES. Cancer. 1965; 18:1131-44. DOI: 10.1002/1097-0142(196509)18:9<1131::aid-cncr2820180914>3.0.co;2-f. View

Monden Y, Nakahara K, Iioka S, Nanjo S, Ohno K, Fujii Y . Recurrence of thymoma: clinicopathological features, therapy, and prognosis. Ann Thorac Surg. 1985; 39(2):165-9. DOI: 10.1016/s0003-4975(10)62558-1. View

Awad W, Symmans P, Dussek J . Recurrence of stage I thymoma 32 years after total excision. Ann Thorac Surg. 1999; 66(6):2106-8. DOI: 10.1016/s0003-4975(98)01077-7. View

Blumberg D, Port J, Weksler B, Delgado R, Rosai J, Bains M . Thymoma: a multivariate analysis of factors predicting survival. Ann Thorac Surg. 1995; 60(4):908-13; discussion 914. DOI: 10.1016/0003-4975(95)00669-c. View

10.

Macchiarini P, Chella A, Ducci F, Rossi B, Testi C, Bevilacqua G . Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma. Cancer. 1991; 68(4):706-13. DOI: 10.1002/1097-0142(19910815)68:4<706::aid-cncr2820680407>3.0.co;2-h. View

11.

Batata M, Martini N, Huvos A, Aguilar R, Beattie Jr E . Thymomas: clinicopathologic features, therapy, and prognosis. Cancer. 1974; 34(2):389-96. DOI: 10.1002/1097-0142(197408)34:2<389::aid-cncr2820340224>3.0.co;2-z. View

12.

Marino M, Muller-Hermelink H . Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus. Virchows Arch A Pathol Anat Histopathol. 1985; 407(2):119-49. DOI: 10.1007/BF00737071. View

13.

Asamura H, Nakajima T, Mukai K, Noguchi M, Shimosato Y . Degree of malignancy of thymic epithelial tumors in terms of nuclear DNA content and nuclear area. An analysis of 39 cases. Am J Pathol. 1988; 133(3):615-22. PMC: 1880827. View

14.

WILKINS Jr E, Grillo H, SCANNELL J, Moncure A, Mathisen D . J. Maxwell Chamberlain Memorial Paper. Role of staging in prognosis and management of thymoma. Ann Thorac Surg. 1991; 51(6):888-92. DOI: 10.1016/0003-4975(91)90999-7. View

15.

BERNATZ P, Harrison E, CLAGETT O . Thymoma: a clinicopathologic study. J Thorac Cardiovasc Surg. 1961; 42:424-44. View

16.

Pescarmona E, Rendina E, Venuta F, DArcangelo E, Pagani M, Ricci C . Analysis of prognostic factors and clinicopathological staging of thymoma. Ann Thorac Surg. 1990; 50(4):534-8. DOI: 10.1016/0003-4975(90)90185-9. View

17.

Masaoka A, Nagaoka Y, Kotake Y . Distribution of thymic tissue at the anterior mediastinum. Current procedures in thymectomy. J Thorac Cardiovasc Surg. 1975; 70(4):747-54. View

18.

Nakahara K, Ohno K, Hashimoto J, Maeda H, Miyoshi S, Sakurai M . Thymoma: results with complete resection and adjuvant postoperative irradiation in 141 consecutive patients. J Thorac Cardiovasc Surg. 1988; 95(6):1041-7. View

19.

Monden Y, Uyama T, Taniki T, Hashimoto J, Fujii Y, Nakahara K . The characteristics of thymoma with myasthenia gravis: a 28-year experience. J Surg Oncol. 1988; 38(3):151-4. DOI: 10.1002/jso.2930380305. View

20.

Regnard J, Magdeleinat P, Dromer C, Dulmet E, de Montpreville V, Levi J . Prognostic factors and long-term results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg. 1996; 112(2):376-84. DOI: 10.1016/S0022-5223(96)70265-9. View